TW241203B - - Google Patents

Info

Publication number
TW241203B
TW241203B TW083100558A TW83100558A TW241203B TW 241203 B TW241203 B TW 241203B TW 083100558 A TW083100558 A TW 083100558A TW 83100558 A TW83100558 A TW 83100558A TW 241203 B TW241203 B TW 241203B
Authority
TW
Taiwan
Application number
TW083100558A
Other languages
Chinese (zh)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of TW241203B publication Critical patent/TW241203B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW083100558A 1993-01-22 1994-01-24 TW241203B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939301289A GB9301289D0 (en) 1993-01-22 1993-01-22 Novel composition

Publications (1)

Publication Number Publication Date
TW241203B true TW241203B (en) 1995-02-21

Family

ID=10729169

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083100558A TW241203B (en) 1993-01-22 1994-01-24

Country Status (10)

Country Link
EP (1) EP0680332A1 (en)
JP (1) JPH08505867A (en)
CN (1) CN1118141A (en)
AU (1) AU5863694A (en)
CA (1) CA2153797A1 (en)
GB (1) GB9301289D0 (en)
NZ (1) NZ259737A (en)
TW (1) TW241203B (en)
WO (1) WO1994016719A1 (en)
ZA (1) ZA94398B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT724435E (en) * 1993-10-21 2002-11-29 Searle & Co UTEIS AMIDINE DERIVATIVES AS NITRIC OXIDE INHIBITORS
GB9604518D0 (en) * 1996-03-02 1996-05-01 Smithkline Beecham Plc Novel compounds
US8088386B2 (en) * 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
JP4897690B2 (en) * 2004-10-12 2012-03-14 ジェネンテック, インコーポレイテッド CRIg polypeptide for prevention and treatment of complement related disorders
GB201800620D0 (en) 2018-01-15 2018-02-28 Univ Manchester C3b Binding Polypeptide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
FR2500825B1 (en) * 1981-02-27 1985-08-23 Torii & Co Ltd NOVEL SUBSTITUTED 4-AMIDINO-PHENYL CARBOXYLATE, PREPARATION METHOD THEREOF AND ANTI-COMPLEMENT AGENT COMPRISING SAME
JPS57179147A (en) * 1981-04-28 1982-11-04 Torii Yakuhin Kk Amidine derivative
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
JPH06503344A (en) * 1990-12-06 1994-04-14 ティーセル サイエンシズ,インコーポレーテッド Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity

Also Published As

Publication number Publication date
GB9301289D0 (en) 1993-03-17
EP0680332A1 (en) 1995-11-08
JPH08505867A (en) 1996-06-25
ZA94398B (en) 1994-11-15
WO1994016719A1 (en) 1994-08-04
CN1118141A (en) 1996-03-06
AU5863694A (en) 1994-08-15
NZ259737A (en) 1997-04-24
CA2153797A1 (en) 1994-08-04

Similar Documents

Publication Publication Date Title
DE9302723U1 (en)
DE9302586U1 (en)
DE9303666U1 (en)
DE9303123U1 (en)
DE9301764U1 (en)
TW241203B (en)
DE9302229U1 (en)
DE9304752U1 (en)
DE9300165U1 (en)
DE9303288U1 (en)
DE9302897U1 (en)
DE9301901U1 (en)
DE9302743U1 (en)
DE9301741U1 (en)
DE9301762U1 (en)
DE9303299U1 (en)
DE9302740U1 (en)
DE9301744U1 (en)
DE9301670U1 (en)
DE9302278U1 (en)
DE9302508U1 (en)
DE9300160U1 (en)
DE9303554U1 (en)
DE9303088U1 (en)
DE9300007U1 (en)